Werewolf Therapeutics Stock Alpha and Beta Analysis
| HOWL Stock | USD 2.00 0.10 5.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Werewolf Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Werewolf Therapeutics over a specified time horizon. Remember, high Werewolf Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Werewolf Therapeutics' market risk premium analysis include:
Beta 2.3 | Alpha (0.24) | Risk 7.75 | Sharpe Ratio 0.0072 | Expected Return 0.0555 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Werewolf |
Werewolf Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Werewolf Therapeutics market risk premium is the additional return an investor will receive from holding Werewolf Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Werewolf Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Werewolf Therapeutics' performance over market.| α | -0.24 | β | 2.30 |
Werewolf Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Werewolf Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Werewolf Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Werewolf Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Werewolf Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Werewolf Therapeutics shares will generate the highest return on investment. By understating and applying Werewolf Therapeutics stock market price indicators, traders can identify Werewolf Therapeutics position entry and exit signals to maximize returns.
Werewolf Therapeutics Return and Market Media
The median price of Werewolf Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 2.14 with a coefficient of variation of 17.05. The daily time series for the period is distributed with a sample standard deviation of 0.38, arithmetic mean of 2.22, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference | 09/03/2024 |
2 | Why Is Werewolf Therapeutics Stock Up 20 percent Today - MSN | 09/27/2024 |
3 | Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancers th Annual Meeting | 10/04/2024 |
4 | Insider Trading | 10/17/2024 |
5 | Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancers th Annual Meeting | 11/07/2024 |
6 | PFM Health Sciences, LP Increases Stake in Werewolf Therapeutics Inc | 11/15/2024 |
7 | Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference | 11/20/2024 |
About Werewolf Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Werewolf or other stocks. Alpha measures the amount that position in Werewolf Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Payables Turnover | 29.12 | 30.58 | Days Of Inventory On Hand | 2.62E-4 | 2.33E-4 |
Werewolf Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Werewolf Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Werewolf Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Werewolf Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Werewolf Therapeutics. Please utilize our Beneish M Score to check the likelihood of Werewolf Therapeutics' management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Werewolf Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Werewolf Therapeutics Backtesting, Werewolf Therapeutics Valuation, Werewolf Therapeutics Correlation, Werewolf Therapeutics Hype Analysis, Werewolf Therapeutics Volatility, Werewolf Therapeutics History and analyze Werewolf Therapeutics Performance. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.